# Protagenic Therapeutics, Inc.\\new: Form 8-K, filed Feb 24, 2025

- Company: [Protagenic Therapeutics, Inc.\\new](/companies/ptix.md) (CIK 1022899)
- Form: 8-K
- Filed: 2025-02-24
- Accepted by EDGAR: Feb 21, 2025, 18:20 ET
- Period: 2025-02-21
- Accession: 0001493152-25-007942
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1022899/000149315225007942/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1022899/000149315225007942/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1022899/000149315225007942/form8-k.htm

Filed Feb 24, 2025.
Source: SEC EDGAR, the filing index for accession 0001493152-25-007942. Last ingested by Listed: Nov 6, 2026, 14:34 ET. No prices; not investment advice.
